GSK Pharma Q2 profit down 23% to ₹101 crore1 min read . Updated: 22 Oct 2018, 03:34 PM IST
GSK Pharma’s total income stood at ₹831.13 crore for the second quarter. It was ₹845.89 crore in the second quarter of 2017-18
New Delhi: GlaxoSmithKline (GSK)Pharmaceuticals on Monday reported 22.67% fall in standalone net profit to ₹ 100.77 crore for the quarter ended 30 September 2018.
The company had posted a net profit of ₹ 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.
Total income of the company stood at ₹ 831.13 crore for the reported quarter. It was ₹ 845.89 crore in the second quarter of 2017-18.
Shares of GSK Pharma were trading at ₹ 1,379.30 per scrip on BSE, down 3.11% from the previous close.